GSK Investigational Site

Cittadella PD, Veneto 35013

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Infections, Bacterial, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects — Completed
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma — Completed
• A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects — Completed
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed